BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31857777)

  • 1. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8
    Chen HY; Wang X; Zhang H; Liu XB; Tan CL
    World J Gastroenterol; 2019 Dec; 25(46):6752-6766. PubMed ID: 31857777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
    Chen YT; Huang ZP; Zhou ZW; He MM
    Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
    van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
    JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
    Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
    Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the American Joint Committee on Cancer Staging Scheme For Resectable Pancreatic Ductal Adenocarcinoma Using Recursive Partitioning Analysis.
    Jiang Y; Su Y; Chen Y; Li Z
    J Cancer; 2017; 8(14):2765-2773. PubMed ID: 28928865
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
    Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
    Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features of T1 pancreatic cancer and validation of the eighth edition AJCC staging system definition using a Korean-Japanese joint cohort and the SEER database.
    Kwon W; Heo JS; Han IW; Kang CM; Hwang HK; Kim SC; Park SJ; Yoon YS; Kim YH; Lim CS; Lee SY; Park T; Takami H; Watanabe N; Shimizu Y; Okuno M; Yamaue H; Kawai M; Seiko H; Nagakawa Y; Osakabe H; Sugiura T; Toyama H; Ohtsuka M; Unno M; Endo I; Kitago M; Jang JY
    J Hepatobiliary Pancreat Sci; 2023 Sep; 30(9):1129-1140. PubMed ID: 36734142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.
    Shi S; Hua J; Liang C; Meng Q; Liang D; Xu J; Ni Q; Yu X
    Ann Surg; 2019 May; 269(5):944-950. PubMed ID: 29334560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multinational validation of the American Joint Committee on Cancer 8th edition pancreatic cancer staging system in a pancreas head cancer cohort.
    Kwon W; He J; Higuchi R; Son D; Lee SY; Kim J; Kim H; Kim SW; Wolfgang CL; Cameron JL; Yamamoto M; Jang JY
    J Hepatobiliary Pancreat Sci; 2018 Sep; 25(9):418-427. PubMed ID: 30118171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: a multicenter cohort study.
    Sheng W; Dong M; Wang G; Shi X; Gao W; Wang K; Song H; Shi G; Tan X
    BMC Cancer; 2019 Oct; 19(1):981. PubMed ID: 31640615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging?
    Kang H; Kim SS; Sung MJ; Jo JH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Park MS; Bang S
    Pancreatology; 2020 Jul; 20(5):952-959. PubMed ID: 32561070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and prognostic factors of patients with stage IB and IIA pancreatic cancer according to the 8
    Li Y; Tang CG; Zhao Y; Cao WY; Qu GF
    World J Gastroenterol; 2017 Apr; 23(15):2757-2762. PubMed ID: 28487613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma.
    Li G; Chen JZ; Chen S; Lin SZ; Pan W; Meng ZW; Cai XR; Chen YL
    Cancer Med; 2020 May; 9(10):3353-3370. PubMed ID: 32181599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of American Joint Committee on Cancer 8
    Yin F; Saad M; Xie H; Lin J; Jackson CR; Ren B; Lawson C; Karamchandani DM; Bernabeu BQ; Jiang W; Dhir T; Zheng R; Schultz CW; Zhang D; Thomas CL; Zhang X; Lai J; Schild M; Zhang X; Liu X
    World J Gastrointest Pharmacol Ther; 2020 Jun; 11(2):25-39. PubMed ID: 32550043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
    Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
    ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN.
    Fan Z; Cheng H; Jin K; Gong Y; Huang Q; Xu J; Ni Q; Yu X; Liu C; Luo G
    World J Surg Oncol; 2019 Aug; 17(1):137. PubMed ID: 31387646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
    Li HJ; Chen YT; Yuan SQ
    Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis.
    Meng Z; Cao M; Zhang Y; Liu Z; Wu S; Wu H
    BMC Gastroenterol; 2019 Apr; 19(1):59. PubMed ID: 31014264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.
    Bilimoria KY; Bentrem DJ; Ko CY; Ritchey J; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Aug; 110(4):738-44. PubMed ID: 17580363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.